BeiGene
2025.04.15
15:34
The Hong Kong stock market's biopharmaceutical sector continued to weaken, with Tiger Pharmaceuticals (03347.HK) falling more than 4%, BeiGene (06160.HK) falling more than 2%, and WuXi AppTec (02359.HK) and others following suit.
2025.04.14
09:45
The Hong Kong stock market's biopharmaceutical sector strengthened in early trading, with Zai Lab (09688.HK) rising more than 12%, Junshi Biosciences (01877.HK) rising more than 5%, and BeiGene (06160.HK), WuXi AppTec (02359.HK) and others following suit.
2025.04.11
14:17
A-share innovative drug concepts fluctuated and rose. Hisun Pharmaceuticals hit the daily limit in the afternoon, and its share price hit a historical high. Ipomoea rose more than 10%. Many stocks including Sinovac Biotech, Sunshine Novo, BioAtla, BeiGene, and Hansen Pharmaceutical rose by more than 5%.
2025.03.31
10:10
A-share innovative drug concepts hit bottom and rebounded, with Shengno Biologics hitting the daily limit, followed by Hansen Pharmaceuticals, BeiGene, Hisun Pharmaceuticals, and Baihua Pharmaceuticals.
10:07
Innovative drug concept bottomed out and rebounded, Shengnuo Biopharma hit the daily limit
The concept of innovative drugs hit bottom and rebounded, Shengno Biopharma hit the daily limit, followed by Hanyu Pharmaceuticals, BeiGene, Hisun Pharmaceuticals, Baihua Pharmaceuticals and others.
2025.03.28
10:14
Hong Kong-listed pharmaceutical stocks fluctuated higher, with Rongchang Biopharmaceuticals rising more than 10%
Hong Kong-listed pharmaceutical stocks fluctuated higher, with Rongchang Biopharma rising more than 10%, followed by Junshi Biosciences, CSPC Pharmaceutical Group, CStone Pharmaceuticals, Innovent Biologics, BeiGene and others.
2025.03.27
18:23
BeiGene: Net loss for 2024 to be approximately US$645 million, down 26.9% from the same period last year
BeiGene announced on the Hong Kong Stock Exchange that the company's annual net loss in 2024 will decrease by approximately 26.9% from the same period last year to approximately US$645 million, and its total revenue in 2024 will increase by approximately US$1.4 billion or approximately 55% year-on-year to approximately US$3.8 billion.
18:20
BeiGene (06160.HK): The annual net loss in 2024 will decrease by approximately 26.9% to approximately US$645 million compared with the same period last year.
15:00
A-share closing review: The three major indexes rose slightly, with chemical and lithography sectors leading the gains
The three major A-share indexes rebounded slightly today. As of the close, the Shanghai Composite Index rose 0.16%, the Shenzhen Component Index rose 0.23%, the ChiNext Index rose 0.24%, and the Beijing Stock Exchange 50 Index fell 0.69%. The total market turnover was 1.2168 trillion yuan, an increase of 36.6 billion yuan from the previous day. More than 1,900 stocks rose in the entire market. In terms of sector themes, the lithography machine, chemical, and innovative drug sectors led the gains; marine engineering equipment and industrial metal concept stocks led the declines. On the market, the chemical sector was repeatedly active, and many stocks such as Zhongyida, Youfu Shares, Danhua Technology, Huarong Chemical, Yaxing Chemical, Hongbaoli, and Huaertai hit the daily limit. The semiconductor sector led the gains, with Xinlai Materials, Haili Shares, Kaimet Gas, and Jianghua Micro hitting the daily limit. Pharmaceutical stocks led the gains, with Huadong Medicine, Hehua Shares, and Aosaikang hitting the daily limit, and BeiGene and Hanyu Pharmaceuticals rising by more than 5%. Offshore equipment stocks fell the most, with Dalian Heavy Industry and Shenkai shares hitting the limit, while Harbin Welding Huatong and Shaoyang Hydraulics fell more than 10%. The non-ferrous metal sector adjusted, with Electrical Alloy and Yongmaotai leading the decline.
10:39
Hong Kong-listed pharmaceutical stocks fluctuated higher, with Innovent Biologics rising more than 8%
Hong Kong-listed pharmaceutical stocks fluctuated higher, with Innovent Biologics rising more than 8%, followed by Rongchang Biopharmaceuticals, Zhaoyan Pharmaceutical, BeiGene, and WuXi Biologics.
2025.03.10
10:14
Hong Kong stocks fluctuated downward, with the Hang Seng Index falling by 1%.
Hong Kong stocks fluctuated downward, with the Hang Seng Index falling by 1% and the Hang Seng Technology Index falling by more than 1.5%. BeiGene and SMIC fell by more than 3%.
09:43
BeiGene's A-shares and H-shares both fell in early trading, with A-shares falling more than 5% and Hong Kong stocks falling nearly 3%.
09:41
BeiGene fell more than 5% during the session
BeiGene fell more than 5% during the session and is now trading at 218.79 yuan.
2025.03.06
05:35
FTSE China A50 Index to include Cambrian, China Unicom and Guotai Junan
On March 5, FTSE Russell announced quarterly review changes to the FTSE China 50 Index, FTSE China A50 Index, FTSE China A150 Index, FTSE China A200 Index, and FTSE China A400 Index. The change will take effect after the close of trading on Friday, March 21, 2025. Specifically, the FTSE China A50 Index, which has attracted the most attention in the market, will include Cambrian-U, China Unicom, and Guotai Junan; China General Nuclear Power, Yili Group, and Luzhou Laojiao will be removed. BeiGene-U, SAIC Group, Seres, Inovance, and ZTE Corporation are on the list of reserve stocks for the FTSE China A50 Index. The reserve list will take effect immediately until the next quarterly review of the constituent stocks. If one or more constituent stocks are deleted, the reserve stocks will be selected.
2025.02.28
09:59
BeiGene's A-share price once surged by more than 9.5%, and its share price hit a record high.
Load More
Email Subscription
Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.
Weekly Highlights
Nvidia (NVDA.O): Blackwell chips have begun production at TSMC's chip factory in Phoenix, Arizona.

2025-04-14

According to ABC News: The helicopter carrying the CEO of Siemens, his wife and young children crashed into the Hudson River in New York City.

2025-04-11

BOE A: Net profit is expected to increase by 63% to 68% year-on-year in the first quarter of 2025

2025-04-15

China Great Wall Information, a subsidiary of China Great Wall, won the bid for the AI acceleration server project of Heilongjiang Rural Credit Cooperatives

2025-04-11

Faraday Future (FFIE.O) announced that it firmly opposes reverse stock splits and is committed to maintaining its listing status on Nasdaq. CEO Mark will meet with White House decision makers.

2025-04-17

ASIA TECH WIRE

Grasp technology trends

Download